Sunday, May 3, 2026
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"bharat-biotech-international-limited-bbil"
Biofabri, Bharat Biotech sign technology transfer agreement for MTBVAC TB vaccine
Biofabri and Bharat Biotech International Limited signed a technology transfer agreement to ensure the MTBVAC TB vaccine is manufactured in India. After successful Phase I and II trials, BBIL plans a Phase III study starting in early 2026.
Latest News
Rashmika’s birthday post for 13-year-old sister Shiman wins hearts online
5 hours ago
India settles for bronze after 0-3 loss to France in Thomas Cup
5 hours ago
India’s Thomas Cup title hopes end with semifinal defeat
5 hours ago
Govt notifies 100 pc FDI in insurance sector under automatic route
5 hours ago
NCW takes suo motu cognisance of Pune minor’s rape-murder
6 hours ago
IDF strikes 120 Hezbollah targets in southern Lebanon
6 hours ago
Chennai Super Kings crush Mumbai Indians by eight wickets
6 hours ago
‘Namaz should be offered in mosques, not disputed places’: Allahabad HC verdict
6 hours ago
.
